SCHEMBL9529543

SCHEMBL9529543

CCCCOC(=O)C(CCc1ccccc1)NC1CSCC(Cc2ccccc2)N(CC(=O)O)C1=O

nearest known ligand 0.58

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ACE P12821 5/20 0.48
ABCB11 O95342 1/20 0.48
AGTR2 P50052 1/20 0.48
PDE3A Q14432 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
KDM4E B2RXH2 1/20 0.47
CYP3A4 P08684 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9526865 0.92 ACE (0.56) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9525550 0.92 ACE (0.56) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9526875 0.92 ACE (0.56) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9526877 0.92 ACE (0.56) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9526720 0.90 ACE (0.56) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9526566 0.89 ACE (0.49) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9526523 0.88 ACE (0.52) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9526256 0.88 ACE (0.48) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9526230 0.87 ACE (0.47) ACEABCB11AGTR2PDE3ATDP1
SCHEMBL9526561 0.86 ACE (0.61) ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0365045-B1 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1993-12-01 EP disclosed
EP-0365045-A1 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1990-04-25 EP disclosed
US-4699905-A HYPOTENSIVE AGENTS SANKYO COMPANY, LIMITED (JP) 1987-10-13 US disclosed
EP-0161801-A2 Perhydrothiazepine derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1985-11-21 EP disclosed